European Respiratory Society statement on airway clearance techniques in adults with bronchiectasis
- PMID: 37142337
- DOI: 10.1183/13993003.02053-2022
European Respiratory Society statement on airway clearance techniques in adults with bronchiectasis
Abstract
Airway clearance techniques (ACTs) are part of the main management strategy for patients with bronchiectasis. Despite being a priority for patients, accessibility, implementation and reporting of ACTs are variable in clinical settings and research studies. This European Respiratory Society statement summarises current knowledge about ACTs in adults with bronchiectasis and makes recommendations to improve the future evidence base. A task force of 14 experts and two patient representatives (10 countries) determined the scope of this statement through consensus and defined six questions. The questions were answered based on systematic searches of the literature. The statement provides a comprehensive review of the physiological rationale for ACTs in adults with bronchiectasis, and the mechanisms of action along with the advantages and disadvantages of each ACT. Evidence on ACTs in clinical practice indicates that the most frequently used techniques are active cycle of breathing techniques, positive expiratory pressure devices and gravity-assisted drainage, although there is limited evidence on the type of ACTs used in specific countries. A review of 30 randomised trials for the effectiveness of ACTs shows that these interventions increase sputum clearance during or after treatment, reduce the impact of cough and the risk of exacerbations, and improve health-related quality of life. Furthermore, strategies for reducing the risk of bias in future studies are proposed. Finally, an exploration of patients' perceptions, barriers and enablers related to this treatment is also included to facilitate implementation and adherence to ACTs.
Copyright ©The authors 2023. For reproduction rights and permissions contact permissions@ersnet.org.
Conflict of interest statement
Conflict of interest: J.D. Chalmers has received research grants from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Gilead Sciences, Grifols, Novartis and Insmed, and received consultancy or speaker fees from AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Insmed, Janssen, Novartis and Zambon. T. Tonia reports acting as the ERS Methodologist. The remaining authors have nothing to disclose.
Similar articles
-
Active cycle of breathing technique versus oscillating PEP therapy versus walking with huffing during an acute exacerbation of bronchiectasis: a randomised, controlled trial protocol.BMC Pulm Med. 2023 Jan 25;23(1):36. doi: 10.1186/s12890-023-02324-8. BMC Pulm Med. 2023. PMID: 36698169 Free PMC article.
-
Airway clearance, mucoactive therapies and pulmonary rehabilitation in bronchiectasis.Respirology. 2019 Mar;24(3):227-237. doi: 10.1111/resp.13459. Epub 2019 Jan 16. Respirology. 2019. PMID: 30650472 Review.
-
Effect of airway clearance techniques in patients experiencing an acute exacerbation of bronchiectasis: a systematic review.Physiother Theory Pract. 2020 Dec;36(12):1300-1315. doi: 10.1080/09593985.2019.1579286. Epub 2019 Feb 18. Physiother Theory Pract. 2020. PMID: 30776932
-
Mucociliary clearance techniques for treating non-cystic fibrosis bronchiectasis: Is there evidence?Int J Immunopathol Pharmacol. 2015 Jun;28(2):150-9. doi: 10.1177/0394632015584724. Epub 2015 Jun 15. Int J Immunopathol Pharmacol. 2015. PMID: 26078380 Review.
-
Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis.Cochrane Database Syst Rev. 2019 Nov 27;2019(11):CD003147. doi: 10.1002/14651858.CD003147.pub5. Cochrane Database Syst Rev. 2019. PMID: 31774149 Free PMC article.
Cited by
-
Airway clearance technique therapy for atelectasis induced by scoliosis surgery: a case report.Front Med (Lausanne). 2025 Feb 11;12:1518935. doi: 10.3389/fmed.2025.1518935. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40007586 Free PMC article.
-
Airway clearance techniques for people with acute exacerbation of COPD: a scoping review.Eur Respir Rev. 2025 Jan 22;34(175):240191. doi: 10.1183/16000617.0191-2024. Print 2025 Jan. Eur Respir Rev. 2025. PMID: 39843161 Free PMC article.
-
Long-Term High-Flow Nasal Therapy in Patients with Bronchiectasis of Different Severity: A Retrospective Cohort Study.J Clin Med. 2024 Oct 15;13(20):6146. doi: 10.3390/jcm13206146. J Clin Med. 2024. PMID: 39458096 Free PMC article.
-
Addressing treatable traits in bronchiectasis through non-pharmacological therapies: a narrative review.J Thorac Dis. 2025 Jun 30;17(6):4302-4322. doi: 10.21037/jtd-2024-2106. Epub 2025 Jun 18. J Thorac Dis. 2025. PMID: 40688306 Free PMC article. Review.
-
A Novel Medical Device for Airway Clearance.J Clin Med. 2025 Jan 30;14(3):907. doi: 10.3390/jcm14030907. J Clin Med. 2025. PMID: 39941578 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources